Cargando…
Cu(3)P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy
PURPOSE: Photothermal therapy (PTT) is a promising anticancer treatment that involves inducing thermal ablation and enhancing antitumor immune responses. However, it is difficult to completely eradicate tumor foci through thermal ablation alone. Additionally, the PTT elicited antitumor immune respon...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258043/ https://www.ncbi.nlm.nih.gov/pubmed/37312933 http://dx.doi.org/10.2147/IJN.S414117 |
_version_ | 1785057409559953408 |
---|---|
author | He, Jiawen Song, Ruixiang Xiao, Fengfeng Wang, Meng Wen, Liewei |
author_facet | He, Jiawen Song, Ruixiang Xiao, Fengfeng Wang, Meng Wen, Liewei |
author_sort | He, Jiawen |
collection | PubMed |
description | PURPOSE: Photothermal therapy (PTT) is a promising anticancer treatment that involves inducing thermal ablation and enhancing antitumor immune responses. However, it is difficult to completely eradicate tumor foci through thermal ablation alone. Additionally, the PTT elicited antitumor immune responses are often insufficient to prevent tumor recurrence or metastasis, due to the presence of an immunosuppressive microenvironment. Therefore, combining photothermal and immunotherapy is believed to be a more effective treatment approach as it can modulate the immune microenvironment and amplify the post-ablation immune response. METHODS: Herein, the indoleamine 2, 3‐dioxygenase‐1 inhibitors (1-MT) loaded copper (I) phosphide nanocomposites (Cu(3)P/1-MT NPs) are prepared for PTT and immunotherapy. The thermal variations of the Cu(3)P/1-MT NPs solution under different conditions were measured. The cellular cytotoxicity and immunogenic cell death (ICD) induction efficiency of Cu(3)P/1-MT NPs were analyzed by cell counting kit-8 assay and flow cytometry in 4T1 cells. And the immune response and antitumor therapeutic efficacy of Cu(3)P/1-MT NPs were evaluated in 4T1-tumor bearing mice. RESULTS: Even at low energy of laser irradiation, Cu(3)P/1-MT NPs remarkably enhanced PTT efficacy and induced immunogenic tumor cell death. Particularly, the tumor-associated antigens (TAAs) could help promote the maturation of dendritic cells (DCs) and antigen presentation, which further activates infiltration of CD8(+) T cells through synergistically inhibiting the indoleamine 2, 3‐dioxygenase‐1. Additionally, Cu(3)P/1-MT NPs decreased the suppressive immune cells such as regulatory T cells (Tregs) and M2 macrophages, indicating an immune suppression modulation effect. CONCLUSION: Cu(3)P/1-MT nanocomposites with excellent photothermal conversion efficiency and immunomodulatory properties were prepared. In addition to enhanced the PTT efficacy and induced immunogenic tumor cell death, it also modulated the immunosuppressive microenvironment. Thereby, this study is expected to offer a practical and convenient approach to amplify the antitumor therapeutic efficiency with photothermal-immunotherapy. |
format | Online Article Text |
id | pubmed-10258043 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-102580432023-06-13 Cu(3)P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy He, Jiawen Song, Ruixiang Xiao, Fengfeng Wang, Meng Wen, Liewei Int J Nanomedicine Original Research PURPOSE: Photothermal therapy (PTT) is a promising anticancer treatment that involves inducing thermal ablation and enhancing antitumor immune responses. However, it is difficult to completely eradicate tumor foci through thermal ablation alone. Additionally, the PTT elicited antitumor immune responses are often insufficient to prevent tumor recurrence or metastasis, due to the presence of an immunosuppressive microenvironment. Therefore, combining photothermal and immunotherapy is believed to be a more effective treatment approach as it can modulate the immune microenvironment and amplify the post-ablation immune response. METHODS: Herein, the indoleamine 2, 3‐dioxygenase‐1 inhibitors (1-MT) loaded copper (I) phosphide nanocomposites (Cu(3)P/1-MT NPs) are prepared for PTT and immunotherapy. The thermal variations of the Cu(3)P/1-MT NPs solution under different conditions were measured. The cellular cytotoxicity and immunogenic cell death (ICD) induction efficiency of Cu(3)P/1-MT NPs were analyzed by cell counting kit-8 assay and flow cytometry in 4T1 cells. And the immune response and antitumor therapeutic efficacy of Cu(3)P/1-MT NPs were evaluated in 4T1-tumor bearing mice. RESULTS: Even at low energy of laser irradiation, Cu(3)P/1-MT NPs remarkably enhanced PTT efficacy and induced immunogenic tumor cell death. Particularly, the tumor-associated antigens (TAAs) could help promote the maturation of dendritic cells (DCs) and antigen presentation, which further activates infiltration of CD8(+) T cells through synergistically inhibiting the indoleamine 2, 3‐dioxygenase‐1. Additionally, Cu(3)P/1-MT NPs decreased the suppressive immune cells such as regulatory T cells (Tregs) and M2 macrophages, indicating an immune suppression modulation effect. CONCLUSION: Cu(3)P/1-MT nanocomposites with excellent photothermal conversion efficiency and immunomodulatory properties were prepared. In addition to enhanced the PTT efficacy and induced immunogenic tumor cell death, it also modulated the immunosuppressive microenvironment. Thereby, this study is expected to offer a practical and convenient approach to amplify the antitumor therapeutic efficiency with photothermal-immunotherapy. Dove 2023-06-07 /pmc/articles/PMC10258043/ /pubmed/37312933 http://dx.doi.org/10.2147/IJN.S414117 Text en © 2023 He et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research He, Jiawen Song, Ruixiang Xiao, Fengfeng Wang, Meng Wen, Liewei Cu(3)P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy |
title | Cu(3)P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy |
title_full | Cu(3)P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy |
title_fullStr | Cu(3)P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy |
title_full_unstemmed | Cu(3)P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy |
title_short | Cu(3)P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy |
title_sort | cu(3)p/1-mt nanocomposites potentiated photothermal-immunotherapy |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258043/ https://www.ncbi.nlm.nih.gov/pubmed/37312933 http://dx.doi.org/10.2147/IJN.S414117 |
work_keys_str_mv | AT hejiawen cu3p1mtnanocompositespotentiatedphotothermalimmunotherapy AT songruixiang cu3p1mtnanocompositespotentiatedphotothermalimmunotherapy AT xiaofengfeng cu3p1mtnanocompositespotentiatedphotothermalimmunotherapy AT wangmeng cu3p1mtnanocompositespotentiatedphotothermalimmunotherapy AT wenliewei cu3p1mtnanocompositespotentiatedphotothermalimmunotherapy |